Amneal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
So good morning, everybody. I'm Christopher Schott from JPMorgan. And it's my pleasure to be introducing Amneal today. From the company, we have Chirag and Chintu Patel, Co-Founders and Co-CEOs. And with that, I'll turn it over to Chirag.
Thank you, Chris. And thank you, everyone, for joining us today. We are thrilled coming back to Amneal 18 months ago. And 18 months ago, we left and came back 5 months ago. So it's not a long time that we were away but very thrilled and excited to rebuild Amneal 2.0, just like how we built Amneal 1.0. So many exciting areas of growth that we have. Let me walk you through.
So this is what we have done, we're calling it the reinvigoration of Amneal, and we had tremendous momentum in 2019 towards the end, entering into 2020. So on a business evolution front, as you saw, we launched 2 key products, first to market. We launched almost 15
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
